EXEFEN IR  - guaifenesin and pseudoephedrine hydrochloride tablet 
Larken Laboratories, Inc.

----------

ExeFen IR

Drug Facts

Active Ingredients (per tablet)

Guaifenesin 400 mg
Pseudoephedrine HCl 60 mg

Purpose

Guaifenesin                                     Expectorant
Pseudoephedrine HCl                   Nasal Decongestant

Uses

Temporarily relieves these symptoms associated with a cough, the common cold, hay fever, or other upper respiratory allergies

Warnings

Do not exceed the recommended dosage

Do not use

Ask a doctor before use if you have

Stop use and ask a doctor if

These could be signs of a serious condition.

If pregnant or breast-feeding

Keep out of the reach of children

In case of accidental overdose, get medical help right away.

Directions

Other Information

Store at 20°-25°C (68°-77°F)

Inactive Ingredients

croscarmellose sodium, magnesium stearate (veg), microcrystalline cellulose, povidone, sodium starch glycolate, and pregelatinized starch.

Questions or Comments?

Call 1-888-527-5522 weekdays from 9:00 am to 4:00 pm CST or go to http://www.larkenlabs.com.

Principal Display Panel

Figure 1: Container Label

Figure 2

43e6997a-figure-01


EXEFEN IR 
guaifenesin and pseudoephedrine hydrochloride   tablet
Product Information
Product TypeHUMAN OTC DRUGNDC Product Code (Source)68047-157
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GUAIFENESIN (GUAIFENESIN) GUAIFENESIN400 mg
PSEUDOEPHEDRINE HYDROCHLORIDE (PSEUDOEPHEDRINE) PSEUDOEPHEDRINE HYDROCHLORIDE60 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM 
MAGNESIUM STEARATE 
CELLULOSE, MICROCRYSTALLINE 
POVIDONE K30 
SODIUM STARCH GLYCOLATE TYPE A POTATO 
STARCH, CORN 
Product Characteristics
ColorWHITEScore2 pieces
ShapeCAPSULESize18mm
FlavorImprint Code LL157
Contains    
Packaging
#NDCPackage DescriptionMultilevel Packaging
168047-157-01100 TABLET In 1 BOTTLENone

Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34101/10/2011

Labeler - Larken Laboratories, Inc. (791043719)
Registrant - Larken Laboratories, Inc. (791043719)
Establishment
NameAddressID/FEIOperations
Sovereign Pharmaceuticals, LLC623168267MANUFACTURE
Revised: 01/2011Larken Laboratories, Inc.